Related Experiment Video
Updated: Mar 8, 2026

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
EPSIN 3, A Novel p53 Target, Regulates the Apoptotic Pathway and Gastric Carcinogenesis
Jinichi Mori1, Chizu Tanikawa2, Naomi Ohnishi3
1Laboratory of Clinical Genome sequencing, Department of Computational biology and medical Sciences, Graduate school of Frontier Sciences, The University of Tokyo, Tokyo, Japan.
Background & Aim:
p53 activation by cellular stresses induces the transcription of hundreds of its target genes. To elucidate the entire picture of its downstream pathway, we screened a cDNA microarray dataset of adriamycin-treated HCT116 p53-/- or p53+/+ cells and identified EPSIN 3 as a novel p53 target.
Methods:
Potential p53 binding sequences in the EPSIN 3 locus were evaluated by reporter and CHIP assays. To investigate the role of EPSIN 3 in the p53 downstream pathway, we assessed DNA damage-induced apoptosis in EPSIN 3-knockdown HCT116 cells or Epsin 3-deficient mice. In addition, we evaluated EPSIN 3 expression levels in various tissues, including gastric adenocarcinoma, human gastric mucosa with or without Helicobacter pylori infection, and mouse acute gastritis tissues induced by indomethacin.
Results:
In response to DNA damage, p53 induced the expression of EPSIN 3 through the p53 binding elements in the EPSIN 3 promoter and the first intron. Knockdown of EPSIN 3 resulted in resistance to DNA damage-induced apoptosis both in vitro and in vivo. EPSIN 3 expression was down-regulated in gastric cancer tissues compared with normal tissues. In addition, Helicobacter pylori infection and indomethacin-induced acute gastritis repressed EPSIN 3 expression in gastric mucosa.
Conclusions:
EPSIN 3 is a novel p53 target and a key mediator of apoptosis. Chronic or acute mucosal inflammation as well as p53 inactivation induced down-regulation of EPSIN 3 and subsequently caused apoptosis resistance, which is a hallmark of cancer cells.
Insights
Epsin 3 is a newly identified p53 target gene that plays a crucial role in apoptosis. Its downregulation, observed in gastric cancer and inflammation, confers resistance to cell death.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- p53 activation by cellular stress triggers target gene transcription.
- Investigating p53's complete downstream pathway is essential.
- EPSIN 3 was identified as a novel p53 target gene.
Purpose of the Study:
- To confirm EPSIN 3 as a p53 target.
- To elucidate the role of EPSIN 3 in p53-mediated apoptosis.
- To analyze EPSIN 3 expression in various conditions and tissues.
Main Methods:
- Reporter and CHIP assays to validate p53 binding sites in the EPSIN 3 locus.
- Assessing DNA damage-induced apoptosis in EPSIN 3-knockdown cells and Epsin 3-deficient mice.
- Evaluating EPSIN 3 expression in gastric cancer, normal gastric mucosa, and gastritis models.
Main Results:
- p53 directly induced EPSIN 3 expression via promoter and intronic binding elements.
- EPSIN 3 knockdown conferred resistance to DNA damage-induced apoptosis in vitro and in vivo.
- EPSIN 3 expression was reduced in gastric cancer and repressed by inflammation (H. pylori, indomethacin).
Conclusions:
- EPSIN 3 is a novel p53 target and a key mediator of apoptosis.
- Downregulation of EPSIN 3, due to inflammation or p53 inactivation, leads to apoptosis resistance.
- Apoptosis resistance is a characteristic feature of cancer cells.
More Related Videos
Related Concept Videos
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
The Extrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

